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Introduction
• Background
– Hyperglycemia and hypoglycemia in 
hospitalized patients are associated with poor 
clinical outcomes, longer length of stay, and 
increased cost 1-4
• Rationale
– Fingerstick blood glucose monitoring is 
the standard of care for hospitalized 
diabetic patients
– Advances in subcutaneous continuous 
glucose monitoring (CGM) technology 
provide the opportunity to more closely 
monitor blood glucose levels in 
hospitalized patients and improve the 
dosage and timing of insulin delivery to 
minimize episodes of hypo/hyperglycemia 




• Gaps in knowledge
– 2017 Consensus Statement on Inpatient Use of Continuous Glucose 
Monitoring5
• “CGM use in the outpatient setting is increasing and will continue to increase. Panel 
members unanimously agreed that continuation of outpatient CGM in the hospital 
should be considered under specific circumstances if proper institutional procedures and 
guidelines are developed. Patients will expect to be allowed to continue use of this 
technology in the inpatient setting and protocols must be in place to allow their safe 
and continued use. We feel that continued CGM use in the hospital has the potential to 
improve outcomes by assisting professionals with identifying hypoglycemic and 
hyperglycemic events. In addition to the possibility of improved outcomes, continued use 
of these devices will increase patient satisfaction. Well-powered studies are needed to 
examine outcomes and accuracy with these devices” 
• Objectives





– Has subcutaneous CGM been demonstrated to 
be an accurate means of measuring blood 
glucose in hospitalized diabetic patients?
• Hypothesis
– Subcutaneous CGM accurately reflects blood 
glucose levels in hospitalized diabetic patients
Study Design
• Study design: systematic review and meta-analysis 
– Published literature since 2015 
• Population: inpatients with diabetes (T1/T2) 
excluding ICU 
• Intervention: CGM  
• Comparison: YSI whole blood glucose or capillary 
(fingerstick) blood glucose measurement
• Outcome: Accuracy 
– Mean absolute relative difference (MARD), coefficient of 





60 results retained 
293 excluded
• 72 CGM not 1o intervention
• 72 accuracy not assessed
• 54 commentary/review
• 41 not hospital-based sample
• 24 case reports
• 23 non-diabetic study population
• 9 other
Full Text Screen –
7 included in analysis
Analysis
• Analysis 
– Qualitative review of measures of accuracy
–Meta-analysis of accuracy as assessed by MARD 
requires individual patient data 
• MARD:  average of the absolute error between all 
CGM values and matched reference values
– Small percentage: CGM readings are close to reference 
• Unable to conduct meta-analysis 
Analysis
Tripyla A, Herzig D, Joachim D, et al. Performance of a factory-calibrated, real-time 
continuous glucose monitoring system during elective abdominal surgery. Diabetes Obes
Metab. 2020;(dw9, 100883645). doi:10.1111/dom.14073
Maeda Y, Nakamura N, Tsujimoto T, Sugano N. Higher blood glucose and larger 
fluctuations detected postoperatively using continuous glucose monitoring: a 
preliminary study following total knee or hip arthroplasty. J exp orthop. 2019;6(1):15. 
doi:10.1186/s40634-019-0181-9
Results
Study Intervention Comparison N
Reutrakul et al. (2020) Dexcom G6 Capillary POC Glucose 9
Galindo et al. (2020) FreeStyle Libre Pro Capillary POC Glucose 97
Migdal et al. (2020) Dexcom G6 Capillary POC Glucose 49
Tripyla et al. (2020) Dexcom G6 Capillary POC Glucose 20
Nair et al. (2020) Dexcom G6 Capillary POC Glucose 10
Gomez et al. (2016) iPro2 Capillary POC Glucose 38







MARD % CGM w/in range of POC Clarke Zone A 
(A & B)
Reutrakul et al. (2020) 9 4.3 (3.1)* 0.927 9.77% NR 84.8% (100%)
Galindo et al. (2020) 97 7.5 (2-30)^ NR
Overall – 14.8%
BG <70 – 27.9%
BG 70-180 – 16.7%
BG >180 – 12.1%
± 15%/15 mg/dL – 61.5%
± 20%/20 mg/dL – 75.8%
± 30%/30 mg/dL – 90.4%    75.1% (98.0%)
Migdal et al. (2020)# 49 1 NR 13.3%
± 15%/15 mg/dL – 69%
± 20%/20 mg/dL – 80%
± 30%/30 mg/dL – 94%    NR (98.1%)
Tripyla et al. (2020)+ 20 1 NR
Overall – 12.7%
BG <70 – NR
BG 70-180 – 12.8%
BG >180 – 12.1% NR 78.8% (99.2%)
Nair et al. (2020)+ 10 2.5 0.76 9.4% NR 89% (NR)
Gomez et al. (2016) 38 6 0.79 12.9% NR NR (91.9%)
Schaupp et al. (2015) 84 7.5 (6-12)~ NR
Overall – 9.6%
BG <70 –21.3%
BG 70-180 – 9.6%
BG >180 – 8.4% NR 88.2% (98.75)
* Mean, (SD)
^ Median (range)
# Pre-imaging values only
+ surgical population
NR not reported 
~ Median (Interquartile range)
Conclusions
• MARD varies across studies and across 
ranges of blood glucose 
– Cannot control for the numerous sources of 
heterogeneity (inclusion criteria, population, 
intervention, outcome measurement, analysis) 
• Small sample sizes limit precision 
• Outcome measures used to assess CGM data 
cannot be pooled using traditional meta-
analysis methods
Future Directions
• Study design and reporting guidelines 
– Standardization across study is necessary to allow for 
determination of suitability of CGM for use in hospitalized 
patients
• Larger trials to allow for greater precision 
• Assessment of accuracy within various subgroups
– Ex. Surgical patients, insulin dependent vs. non-insulin 
dependent DM 
• Assessment of clinical outcomes and process 
measures:
– Number of hyper/hypo glycemic episodes,  nursing 
workload, patient satisfaction  
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